Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction
Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression
Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
A study by Agharkar Research Institute (ARI), Pune, has discovered that a protein secreted from intervertebral disc cells induces disc regeneration in aged degenerated discs
This dense phase often resembles liquid droplets exhibiting higher protein density and weaker molecular motion than the surrounding medium.
GenNext and Kiko Tech will provide sales and marketing, customer service, technical support, training, and related logistical efforts for Flash Oxidation Protein Footprinting Systems.
Peak Proteins has collaborated closely with Sygnature Discovery for several years and together the companies have supported a number of integrated drug discovery programmes
It plans to deliver over 300 million doses to the Indian government
Subscribe To Our Newsletter & Stay Updated